Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3961647> ?p ?o }
Showing triples 1 to 29 of
29
with 100 triples per page.
- Q3961647 subject Q7004986.
- Q3961647 abstract "Cytokine release syndrome is a common immediate complication occurring with the use of anti-T cell antibody infusions such as ATG, OKT3, and TGN1412, but also with the CD-20 antibody rituximab. Severe cases are known as cytokine storms.The pathogenesis is that the antibodies bind to the T cell receptor, activating the T cells before they are destroyed. The cytokines released by the activated T cells produce a type of systemic inflammatory response similar to that found in severe infection characterised by hypotension, pyrexia, and rigors. The patient feels very unwell, as if in a high fever – indeed, the cytokine release syndrome is effectively a type of non-infective fever.Deaths due to cytokine release syndrome with OKT3 (muromonab-CD3) have been reported, and it can cause life-threatening pulmonary edema if the patient is fluid overloaded. However, if treated appropriately it is usually not dangerous, just extremely unpleasant for the patient.The effect is greatly reduced by using low dose OKT3, e.g. 2 mg instead of 5 mg, slow infusion instead of rapid injection, intravenous administration of an anti-histamine (such as chlorphenamine) and a corticosteroid (such as hydrocortisone) prior to starting the ATG/OKT3 infusion, with further doses of anti-histamine and steroid given during the infusion if necessary, acetaminophen 500 mg by mouth 1 hour before infusion to prevent fever. Moreover, it is recommended that any overhydration to be corrected before the administration of the first dose either by dialysis or with intravenous furosemide, to prevent the possible development of pulmonary oedema.".
- Q3961647 wikiPageWikiLink Q1060890.
- Q3961647 wikiPageWikiLink Q1076369.
- Q3961647 wikiPageWikiLink Q166231.
- Q3961647 wikiPageWikiLink Q190875.
- Q3961647 wikiPageWikiLink Q193529.
- Q3961647 wikiPageWikiLink Q210420.
- Q3961647 wikiPageWikiLink Q212354.
- Q3961647 wikiPageWikiLink Q275419.
- Q3961647 wikiPageWikiLink Q2759182.
- Q3961647 wikiPageWikiLink Q324089.
- Q3961647 wikiPageWikiLink Q38933.
- Q3961647 wikiPageWikiLink Q412323.
- Q3961647 wikiPageWikiLink Q416494.
- Q3961647 wikiPageWikiLink Q420133.
- Q3961647 wikiPageWikiLink Q424452.
- Q3961647 wikiPageWikiLink Q57055.
- Q3961647 wikiPageWikiLink Q7004986.
- Q3961647 wikiPageWikiLink Q776030.
- Q3961647 wikiPageWikiLink Q79460.
- Q3961647 wikiPageWikiLink Q857667.
- Q3961647 name "Cytokine release syndrome".
- Q3961647 type Disease.
- Q3961647 type Thing.
- Q3961647 type Q12136.
- Q3961647 comment "Cytokine release syndrome is a common immediate complication occurring with the use of anti-T cell antibody infusions such as ATG, OKT3, and TGN1412, but also with the CD-20 antibody rituximab. Severe cases are known as cytokine storms.The pathogenesis is that the antibodies bind to the T cell receptor, activating the T cells before they are destroyed.".
- Q3961647 label "Cytokine release syndrome".
- Q3961647 name "Cytokine release syndrome (CRS)".